Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Olsalazine in active ulcerative colitis.

W S Selby, G D Barr, A Ireland

    British Medical Journal (Clinical Research Ed.)
    |November 16, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Physical function and physical activity in adults with X-linked hypophosphatemia.

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2022
    Same author

    Physical function in UK adults with osteogenesis imperfecta: a cross-sectional analysis of the RUDY study.

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2020
    Same author

    Pregnancy and lactation, a challenge for the skeleton.

    Endocrine connections·2020
    Same author

    Long-Term Endurance and Power Training May Facilitate Motor Unit Size Expansion to Compensate for Declining Motor Unit Numbers in Older Age.

    Frontiers in physiology·2019
    Same author

    Breech presentation is associated with lower adolescent tibial bone strength.

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2019
    Same author

    Fibula: The Forgotten Bone-May It Provide Some Insight On a Wider Scope for Bone Mechanostat Control?

    Current osteoporosis reports·2018
    Same journal

    Early retirement for consultants.

    British medical journal (Clinical research ed.)·2010
    Same journal

    From COMAR: Essential troika of teaching, research, and clinical care.

    British medical journal (Clinical research ed.)·2010
    Same journal

    Parliament's two way pull on the NHS.

    British medical journal (Clinical research ed.)·2010
    Same journal

    Conference Report: After the summit.

    British medical journal (Clinical research ed.)·2010
    Same journal

    Council election: South Western regional vacancy 1988-90.

    British medical journal (Clinical research ed.)·2010
    Same journal

    Health managers support taxation based service.

    British medical journal (Clinical research ed.)·2010
    See all related articles

    Olsalazine shows promise for treating ulcerative colitis. Oral olsalazine significantly improved symptoms in patients with mild ulcerative colitis, though enema use did not yield significant results.

    Area of Science:

    • Gastroenterology
    • Pharmacology

    Background:

    • Ulcerative colitis is a chronic inflammatory bowel disease.
    • Olsalazine, a prodrug of 5-aminosalicylic acid, is a potential therapeutic agent.

    Purpose of the Study:

    • To evaluate the efficacy of olsalazine in treating mildly active ulcerative colitis.
    • To compare the effects of rectal and oral olsalazine administration.

    Main Methods:

    • Two randomized, placebo-controlled trials were conducted.
    • Trial 1: 60 patients received olsalazine (1g nightly enema) or placebo for two weeks.
    • Trial 2: 40 patients received oral olsalazine (2g daily) or placebo capsules for two weeks.

    Main Results:

    • Rectal olsalazine showed no significant clinical or sigmoidoscopic improvement compared to placebo.

    Related Experiment Videos

  • Oral olsalazine demonstrated significant clinical and sigmoidoscopic improvement versus placebo.
  • No significant differences were observed in the rectal administration trial.

    • Conclusions:

    • Oral olsalazine appears effective for treating mildly active ulcerative colitis.
    • Further research is needed to determine olsalazine's role in maintaining remission.